Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is SunOpta, Inc. (USA) (STKL) A Good Stock To Buy?

Page 1 of 2

As we already know from media reports and hedge fund investor letters, many hedge funds lost money in the third quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with healthcare among them. Nevertheless, most investors decided to stick to their bullish theses and their long-term focus allows us to profit from the recent declines. In particular, let’s take a look at what hedge funds think about SunOpta, Inc. (USA) (NASDAQ:STKL) in this article.

SunOpta, Inc. (USA) (NASDAQ:STKL) has experienced an increase in activity from the world’s largest hedge funds in recent months. STKL was in 20 hedge funds’ portfolios at the end of September. There were 15 hedge funds in our database with STKL positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as GenMark Diagnostics, Inc (NASDAQ:GNMK), NewBridge Bancorp (NASDAQ:NBBC), and Neos Therapeutics Inc (NASDAQ:NEOS) to gather more data points.

Follow Sunopta Inc. (NASDAQ:STKL)
Trade (NASDAQ:STKL) Now!

According to most investors, hedge funds are perceived as unimportant, outdated financial vehicles of yesteryear. While there are greater than 8000 funds trading today, Our experts hone in on the leaders of this club, approximately 700 funds. These investment experts preside over the lion’s share of the smart money’s total capital, and by watching their highest performing equity investments, Insider Monkey has identified several investment strategies that have historically outpaced the broader indices. Insider Monkey’s small-cap hedge fund strategy outstripped the S&P 500 index by 12 percentage points per year for a decade in their back tests.

Keeping this in mind, let’s take a gander at the new action surrounding SunOpta, Inc. (USA) (NASDAQ:STKL).

How are hedge funds trading SunOpta, Inc. (USA) (NASDAQ:STKL)?

Heading into Q4, a total of 20 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 33% from one quarter earlier. With the smart money’s capital changing hands, there exists an “upper tier” of key hedge fund managers who were boosting their holdings substantially (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Tourbillon Capital Partners, managed by Jason Karp, holds the biggest position in SunOpta, Inc. (USA) (NASDAQ:STKL). Tourbillon Capital Partners has a $41.4 million position in the stock, comprising 1.1% of its 13F portfolio. Sitting at the No. 2 spot is Greg Boland’s West Face Capital, with a $41.2 million position; the fund has 17.1% of its 13F portfolio invested in the stock. Some other members of the smart money with similar optimism include Mariko Gordon’s Daruma Asset Management, Chuck Royce’s Royce & Associates and Jim Simons’ Renaissance Technologies.

Page 1 of 2
Loading Comments...